Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemophilia A and hemophilia B, hyperoxaluria Type 1, and alpha-1 antitrypsin deficiency. Its ex vivo pipeline includes NTLA-5001 for the treatment of acute myeloid leukemia; and proprietary programs focused on developing engineered cell therapies to treat various oncological and autoimmune disorders. In addition, it offers tools comprising of Clustered, Regularly Interspaced Short Palindromic Repeats/CRISPR associated 9 (CRISPR/Cas9) system. Intellia Therapeutics, Inc. has license and collaboration agreements with Novartis Institutes for BioMedical Research, Inc. to engineer hematopoietic stem cells for the treatment of sickle cell disease; Regeneron Pharmaceuticals, Inc. to co-develop potential products for the treatment of hemophilia A and hemophilia B; Ospedale San Raffaele; and a strategic collaboration with SparingVision SAS to develop novel genomic medicines utilizing CRISPR/Cas9 technology for the treatment of ocular diseases. The company was formerly known as AZRN, Inc. Intellia Therapeutics, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Intellia Therapeutics Inc..
Intellia Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Intellia Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Intellia Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Intellia Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Intellia Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Intellia Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Intellia Therapeutics Inc.- Key Facts
2.2 Intellia Therapeutics Inc.- Geographic Locations
2.3 Intellia Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Intellia Therapeutics Inc.- Business Divisions
2.5 Intellia Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Intellia Therapeutics Inc. Strategic Analysis Review
3.1 Intellia Therapeutics Inc.- Key Strategies
3.2 Intellia Therapeutics Inc.- Company Outlook Statement
3.3 Intellia Therapeutics Inc.- SWOT Analysis
3.3.1 Intellia Therapeutics Inc.- Key Strengths
3.3.2 Intellia Therapeutics Inc.- Key Weaknesses
3.3.3 Intellia Therapeutics Inc.- Potential Opportunities
3.3.4 Intellia Therapeutics Inc.- Potential Threats
3.4 Intellia Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Intellia Therapeutics Inc.- Business Overview
4.2 Intellia Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Intellia Therapeutics Inc.- Key Products
5.2 Intellia Therapeutics Inc.- Key Service Areas
5.3 Intellia Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Intellia Therapeutics Inc.- Company History
6.2 Intellia Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Intellia Therapeutics Inc.- Income Statements
7.2 Intellia Therapeutics Inc.- Balance Sheet
7.3 Intellia Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Intellia Therapeutics Inc.- Direct Competitors
8.2 Intellia Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Intellia Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Intellia Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
